BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6096758)

  • 1. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
    Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
    Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
    Schusdziarra V; Lenz N; Schick R; Maier V
    Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CCK on food intake in man: physiological or pharmacological effect?
    Schick RR; Schusdziarra V; Mössner J; Neuberger J; Schröder B; Segmüller R; Maier V; Classen M
    Z Gastroenterol; 1991 Feb; 29(2):53-8. PubMed ID: 1714670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B; Hedner P; Lundquist I
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):115-20. PubMed ID: 3518338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
    Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
    Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of amino acid infusions and effect of cholecystokinin on insulin release in dogs.
    Schmid R; Schusdziarra V; Butscher H; Classen M
    Clin Physiol Biochem; 1990; 8(5):244-9. PubMed ID: 2103898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of motilin-induced somatostatin release in dogs by naloxone.
    Schick R; Schusdziarra V
    Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.
    Rushakoff RJ; Goldfine ID; Carter JD; Liddle RA
    J Clin Endocrinol Metab; 1987 Sep; 65(3):395-401. PubMed ID: 3305550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-casomorphins and analogs on insulin release in dogs.
    Schusdziarra V; Schick A; de la Fuente A; Specht J; Klier M; Brantl V; Pfeiffer EF
    Endocrinology; 1983 Mar; 112(3):885-9. PubMed ID: 6337048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1984 May; 114(5):1770-5. PubMed ID: 6143659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig.
    Ahrén B; Mårtensson H; Nobin A
    Pancreas; 1988; 3(3):279-84. PubMed ID: 2898779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfation of CCK-8 on its stimulation of the endocrine and exocrine secretion from the isolated perfused porcine pancreas.
    Jensen SL; Holst JJ; Nielsen OV; Rehfeld JF
    Digestion; 1981; 22(6):305-9. PubMed ID: 6277714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
    Mineo H; Kamita H; Muto H; Ito M; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):171-4. PubMed ID: 9243718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.